FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2313020796> ?p ?o ?g. }

• W2313020796 abstract "There is a recent increase in the use of patient-derived tumor xenografts (PDX) engrafted into immunodeficient mice as improved preclinical models of patient tumors. An important component in the validation of disease-specific PDXs for clinical relevance is comparing the genomic alterations and the response to standard agents. The CReMEC collection of 54 colorectal PDX has been recently reported to mimic the clinical situation for histopathological and molecular diversity of colorectal cancer. We further analyze here this colorectal PDX collection in regard to robust human patient molecular features: 1) Alterations in both PI3K and RTK-Ras pathways; 2) Role of oncogenic activation of EGFR-Ras downstream signaling on response to cetuximab. The Cancer Genome Atlas Network (TCGA) newly reported a large genome-scale analysis of 276 colorectal cancer tissue samples, showing common genetic alterations in the PI3K and RTK-RAS pathways, with mutual exclusions in the PI3K pathway. The analysis of the PDX panel by CGH array, RNA expression (microarray, real-time qRT-PCR) and exome sequencing confirmed activation with mutual exclusion in PI3K pathway (IGF2 focal amplification/overexpression; IRS2 overexpression, mutation of PIK3CA, PIK3R1 and PTEN homozygous deletion). In RTK-Ras pathway, frequencies of genomic abnormalities (ERBB2 mutation/amplification; mutation of ERBB3, NRAS, KRAS and BRAF) in PDXs are fully in line with the TCGA patient collection. The response to cetuximab of 52 subcutaneous engrafted PDX (including 24 KRAS mutated PDX) has been analyzed according to translated clinical criteria: xenograft regression as been defined as a partial response (decrease of at least 70% of the tumor volume measured at the beginning of the treatment) or as a complete response. In this unselected population, tumor regression occurred in 8 out of 52 cases (15%); all were KRAS wild type tumors. The percentage of responders was enriched up to 30% (7/23) when PTEN deletion and mutations of KRAS, BRAF, and PIK3CA are concomitantly excluded. These results completely fit with recent publication of data in patients treated with anti-EGFR antibodies. Taken together, these results demonstrate that colorectal PDXs are representative clinical colorectal tumor models. They also underline their interest as appropriate tools to identify and test new targeted therapeutics. Citation Format: Manoel Nunes, Louis-Bastien Weiswald, Patricia Vrignaud, Sophie Vacher, Edouard Turlotte, Sophie Richon, Dominique Bellet, Sergio Roman-Roman, Ivan Bieche, Virginie Dangles-Marie. Similar PI3K and RTK-Ras status in patient derived colorectal cancer-xenografts and patients. [abstract]. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2013;73(8 Suppl):Abstract nr LB-34. doi:10.1158/1538-7445.AM2013-LB-34" @default.
• W2313020796 created "2016-06-24" @default.
• W2313020796 creator A5019005462 @default.
• W2313020796 creator A5021696406 @default.
• W2313020796 creator A5022278280 @default.
• W2313020796 creator A5037964830 @default.
• W2313020796 creator A5039706842 @default.
• W2313020796 creator A5056358466 @default.
• W2313020796 creator A5071294409 @default.
• W2313020796 creator A5075567455 @default.
• W2313020796 creator A5090178944 @default.
• W2313020796 creator A5090660149 @default.
• W2313020796 date "2013-04-15" @default.
• W2313020796 modified "2023-10-17" @default.
• W2313020796 title "Abstract LB-34: Similar PI3K and RTK-Ras status in patient derived colorectal cancer-xenografts and patients." @default.
• W2313020796 doi "https://doi.org/10.1158/1538-7445.am2013-lb-34" @default.
• W2313020796 hasPublicationYear "2013" @default.
• W2313020796 type Work @default.
• W2313020796 sameAs 2313020796 @default.
• W2313020796 citedByCount "0" @default.
• W2313020796 crossrefType "proceedings-article" @default.
• W2313020796 hasAuthorship W2313020796A5019005462 @default.
• W2313020796 hasAuthorship W2313020796A5021696406 @default.
• W2313020796 hasAuthorship W2313020796A5022278280 @default.
• W2313020796 hasAuthorship W2313020796A5037964830 @default.
• W2313020796 hasAuthorship W2313020796A5039706842 @default.
• W2313020796 hasAuthorship W2313020796A5056358466 @default.
• W2313020796 hasAuthorship W2313020796A5071294409 @default.
• W2313020796 hasAuthorship W2313020796A5075567455 @default.
• W2313020796 hasAuthorship W2313020796A5090178944 @default.
• W2313020796 hasAuthorship W2313020796A5090660149 @default.
• W2313020796 hasConcept C121608353 @default.
• W2313020796 hasConcept C126322002 @default.
• W2313020796 hasConcept C21790070 @default.
• W2313020796 hasConcept C2777609662 @default.
• W2313020796 hasConcept C2779998722 @default.
• W2313020796 hasConcept C2781187634 @default.
• W2313020796 hasConcept C502942594 @default.
• W2313020796 hasConcept C526805850 @default.
• W2313020796 hasConcept C54355233 @default.
• W2313020796 hasConcept C62478195 @default.
• W2313020796 hasConcept C71924100 @default.
• W2313020796 hasConcept C86554907 @default.
• W2313020796 hasConcept C86803240 @default.
• W2313020796 hasConceptScore W2313020796C121608353 @default.
• W2313020796 hasConceptScore W2313020796C126322002 @default.
• W2313020796 hasConceptScore W2313020796C21790070 @default.
• W2313020796 hasConceptScore W2313020796C2777609662 @default.
• W2313020796 hasConceptScore W2313020796C2779998722 @default.
• W2313020796 hasConceptScore W2313020796C2781187634 @default.
• W2313020796 hasConceptScore W2313020796C502942594 @default.
• W2313020796 hasConceptScore W2313020796C526805850 @default.
• W2313020796 hasConceptScore W2313020796C54355233 @default.
• W2313020796 hasConceptScore W2313020796C62478195 @default.
• W2313020796 hasConceptScore W2313020796C71924100 @default.
• W2313020796 hasConceptScore W2313020796C86554907 @default.
• W2313020796 hasConceptScore W2313020796C86803240 @default.
• W2313020796 hasLocation W23130207961 @default.
• W2313020796 hasOpenAccess W2313020796 @default.
• W2313020796 hasPrimaryLocation W23130207961 @default.
• W2313020796 hasRelatedWork W1754797577 @default.
• W2313020796 hasRelatedWork W1963905418 @default.
• W2313020796 hasRelatedWork W2013400270 @default.
• W2313020796 hasRelatedWork W2024155433 @default.
• W2313020796 hasRelatedWork W2051444430 @default.
• W2313020796 hasRelatedWork W2068216731 @default.
• W2313020796 hasRelatedWork W2079545401 @default.
• W2313020796 hasRelatedWork W2111905790 @default.
• W2313020796 hasRelatedWork W2166310356 @default.
• W2313020796 hasRelatedWork W2265085667 @default.
• W2313020796 hasRelatedWork W2320135056 @default.
• W2313020796 hasRelatedWork W2325736294 @default.
• W2313020796 hasRelatedWork W2463612609 @default.
• W2313020796 hasRelatedWork W2739568978 @default.
• W2313020796 hasRelatedWork W2802690479 @default.
• W2313020796 hasRelatedWork W2885192016 @default.
• W2313020796 hasRelatedWork W3012993546 @default.
• W2313020796 hasRelatedWork W3034612993 @default.
• W2313020796 hasRelatedWork W3043838444 @default.
• W2313020796 hasRelatedWork W3111101134 @default.
• W2313020796 isParatext "false" @default.
• W2313020796 isRetracted "false" @default.
• W2313020796 magId "2313020796" @default.
• W2313020796 workType "article" @default.